HOME
ABOUT
WHAT IS CLLAN
WHY IS CLLAN IMPORTANT?
CLLAN OBJECTIVES
LEADERSHIP
CONTACT
NEWSLETTER
SEARCH
CLL INFORMATION
MEMBERSHIP
MEMBERSHIP
MEMBERS
TRIBUTE
INITIATIVES
*NEW*
CLL HORIZONS 2025
CLL IC TASKFORCE
About us
Become an industry partner
CLL IMMUNE CHALLENGES WHITE PAPER
*NEW*
BTKi: A PATIENT INFORMATION GUIDE
*NEW*
2023 GLOBAL SURVEY INSIGHTS
LEUKEMIA CARER EXPERIENCE SURVEY
LEUKEMIA PATIENT EXPERIENCE SURVEY
SURVEY COMPARISON REPORT
CLL ADVOCACY SURVEY
WORLD CLL DAY
ICBCC
WORKSHOPS AND WEBINARS
BLOOD CANCER PATIENT ADVOCATES ACADEMY
CLLAN TOOLS
*NEW*
CLL CLINICAL TRIALS HUB
RESOURCE HUB
ADVOCACY TOOLKIT
COVID-19 RESOURCES
STATEMENT
NEWS & EVENTS
NEWS & EVENTS
NEWSLETTER
Research & Data
CREATING EVIDENCE AND PUBLISHING IT
Barking up the right tree on access, policy and research. Why evidence based advocacy?
| Author: Jan Geissler| Type: PDF document | Source:
CML Horizons 2018.
Back to Search